Other Events ·
At its June 25, 2026, Annual Meeting of Stockholders, Myomo, Inc. approved an amendment to its 2018 Stock Option and…
MYOMyomo, Inc.
At its June 25, 2026, Annual Meeting of Stockholders, Myomo, Inc. approved an amendment to its 2018 Stock Option and Incentive Plan to increase available shares by 1,833,000. Additionally, stockholders approved a charter amendment to increase the total authorized common stock to 100,000,000 shares, which became effective upon filing with the Delaware Secretary of State. The meeting also resulted in the election of Paul R. Gudonis and Thomas F. Kirk as Class III directors and the ratification of CBIZ CPAs P.C. as the independent auditor. Myomo, Inc. is a medical technology company that develops wearable robotic devices.